Related Experiment Video
Updated: Dec 20, 2025

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Predicting Participation in Psychiatric Randomized Controlled Trials: Insights From the STEP-BD
Alisa B Busch1, Yulei He1, Katya Zelevinsky1
1Dr. Busch and Ms. Zelevinsky are with the Department of Health Care Policy, Harvard Medical School, Boston (e-mail: abusch@hcp.med.harvard.edu ), where Dr. He was affiliated when this work was done. Dr. Busch is also with McLean Hospital, Belmont, Massachusetts. Dr. He is now with the Office of Research and Methodology, National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville, Maryland. Dr. O'Malley is with the Dartmouth Institute of Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, Lebanon, New Hampshire.
Randomized controlled trial (RCT) participation in bipolar depression studies was linked to lack of insurance and greater symptom severity. However, study site significantly influenced enrollment more than patient characteristics.
Area of Science:
- Clinical Psychology
- Psychiatric Research
- Medical Sociology
Background:
- Differences between participants and non-participants in randomized controlled trials (RCTs) can affect the generalizability of findings.
- The Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) enrolled patients with bipolar disorder, allowing for observational participation and optional RCT enrollment during depressive episodes.
Purpose of the Study:
- To investigate whether patients participating in RCTs for acute bipolar depression differ from those in the observational arm of the STEP-BD study.
- To identify demographic, clinical, and site-related factors associated with RCT participation.
Main Methods:
- Logistic regression models were used to estimate the odds of RCT enrollment among 2,222 STEP-BD participants with acute bipolar depression.
- Predictor variables included patient demographics, clinical severity (Clinical Global Impression scale), comorbidities, and study site.
- Area under the receiver operating characteristic curve (AUC) was calculated to assess the predictive power of study site on RCT participation.
Main Results:
- RCT participation was associated with having no insurance (OR=1.58) and greater symptom severity (OR=1.52).
- Study site emerged as the most significant predictor of RCT enrollment, with predicted probabilities ranging from 8% to 31%.
- The model including site had a higher AUC (.70) compared to the model excluding site (.61), indicating site's strong influence.
Conclusions:
- Few demographic or clinical differences were observed between RCT participants and the observational group in the STEP-BD study.
- Study site was the strongest determinant of RCT participation, suggesting potential biases in generalizability.
- Further research is needed to explore site characteristics influencing participation and their impact on patient outcomes in real-world settings.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
Related Concept Videos
Blinding
Blind Procedures
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Regression Toward the Mean
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview